Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-24T10:58:26.508Z Has data issue: false hasContentIssue false
  • English
  • Français

Polymorphism C242T of the gene of the p22phox subunit for nicotinamide adenine dinucleotide phosphate oxidase, and erythrocytic antioxidant enzymes, in patients with tetralogy of Fallot

Published online by Cambridge University Press:  20 April 2007

António Guerra ,
Carla Rego ,
Constança Coelho ,
Nuno Guimarães ,
Catarina Thiran ,
Álvaro Aguiar ,
José Carlos Areias  and
Manuel Bicho
António Guerra
Affiliation:
Department of Paediatrics, Hospital S. João/Faculty of Medicine – University of Porto, Portugal
Carla Rego
Affiliation:
Department of Paediatrics, Hospital S. João/Faculty of Medicine – University of Porto, Portugal
Constança Coelho
Affiliation:
Genetics Laboratory, Faculty of Medicine – University of Lisbon, Portugal
Nuno Guimarães
Affiliation:
Genetics Laboratory, Faculty of Medicine – University of Lisbon, Portugal
Catarina Thiran
Affiliation:
Genetics Laboratory, Faculty of Medicine – University of Lisbon, Portugal
Álvaro Aguiar
Affiliation:
Department of Paediatrics, Hospital S. João/Faculty of Medicine – University of Porto, Portugal
José Carlos Areias
Affiliation:
Department of Paediatrics, Hospital S. João/Faculty of Medicine – University of Porto, Portugal
Manuel Bicho
Affiliation:
Genetics Laboratory, Faculty of Medicine – University of Lisbon, Portugal
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: Nicotinamide adenine dinucleotide phosphate oxidase of the vascular cell membrane is an important source of reactive oxygen species. The aim of our study was to evaluate the possible influence of the p22phox C242T gene polymorphism on blood pressure and some markers of oxidative stress in children with tetralogy of Fallot. Methods: After surgical repair in early life, we recruited 38 children, aged 11.7 plus or minus 3.2 years, including 185 healthy individuals as controls for the purposes of establishing frequencies of alleles and genotypes. From this latter group, we matched a sub-sample of 53 healthy caucasian children, aged 11.0 plus or minus 1.0 years, in order to compare enzymic activities. Results: The children with tetralogy of Fallot showed significantly lower values of low-molecular-weight protein tyrosine phosphatase, particularly in carriers of CC genotype for the p22phox gene, with values of 145.2 plus or minus 77.4 μmol/g Hb/h, compared to controls, at 344.4 plus or minus 100.4 μmol/g Hb/h (p less than 0.001). Methemoglobin reductase activity in the patients with tetralogy was also lower in those with the CC genotype, at 9.8 plus or minus 3.2 μmol/g Hb−1 min−1 compared to 24.2 plus or minus 11.8 μmol/g Hb−1 min−1 as measured in the controls (p less than 0.01). Lower systolic (p less than 0.05) and diastolic (p less than 0.01) blood pressures were also observed in the patients with tetralogy of Fallot. Conclusions: Patients with tetralogy of Fallot having the CC genotype may be at a higher state of oxidative stress than T allele carriers, a finding which could have prognostic implications. Long term follow-up of these patients, however, may be necessary in order to draw definite conclusions.

Keywords

Cyanotic congenital heart diseaseNAD(P)H oxidaseoxidative stress
Type
Original Article
Information
Cardiology in the Young , Volume 17 , Issue 3 , June 2007 , pp. 295 - 300
Copyright
© 2007 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chaturvedi RR, Shore DF, Lincoln C, et al. Acute right ventricular restrictive physiology after repair of tetralogy of Fallot: association with myocardial injury and oxidative stress. Circulation 1999; 100: 1540–1547.Google Scholar
Li RK, Mickle DA, Weisel RD, et al. Effect of oxygen tension on the anti-oxidant enzyme activities of tetralogy of Fallot ventricular myocytes. J Mol Cell Cardiol 1989; 21: 567–575.Google Scholar
Morita K, Ihnken K, Buckberg GD, Sherman MP, Young HH, Ignarro LJ. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest 1994; 93: 2658–2666.Google Scholar
Teoh KH, Mickle DA, Weisel RD, et al. Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass. J Thorac Cardiovasc Surg 1992; 104: 159–164.Google Scholar
Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc Drugs Ther 1991; 5 Suppl 2: 249–268.Google Scholar
Zalba G, San José G, Moreno MU, et al. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 2001; 38: 1395–1399.Google Scholar
Lacy F, O'Connor DT, Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 1998; 16: 291–303.Google Scholar
Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griedling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996; 271: 23317–23321.Google Scholar
Guzik TJ, West NE, Black E, et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000; 102: 1744–1747.Google Scholar
Griendling K, Ushio-Fukai M. NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med 1997; 7: 301–306.Google Scholar
Xu D, Rovira II, Finkel T. Oxidants painting the cysteine chapel: redox regulation of PTPs. Dev Cell 2002; 2: 251–252.Google Scholar
Raugei G, Ramponi G, Chiarugi P. Low molecular weight protein tyrosine phosphatases: small, but smart. Cell Mol Life Sci 2002; 59: 941–949.Google Scholar
Lukyanenko LM, Kozlova NM, Slobozhanina EI. Activity of membrane-bound NADH-methemoglobin reductase and physical state of lipids in erythrocyte membranes. Bioelectrochemistry 2004; 62: 191–193.Google Scholar
Inal ME, Eguz AM. The effects of isosorbide dinitrate on methemoglobin reductase enzyme activity and antioxidant states. Cell Biochem Funct 2004; 22: 129–133.Google Scholar
Fomon SJ. Nutritional disorders of children: prevention, screening and follow-up. Washington, DC: Dept. Health, Education and Welfare; 1977. Publication (HSA) 77–5104.
Cameron N. The methods of auxological anthropometry. In: Falkner F, Tanner FM (eds.). Human growth: A comprehensive treatise. 2nd edition. Plenum Press, New York, 1986; pp. 13–45.
Lee J, Kolonel LN, Hinds W. Relative merits of the weight-corrected for height indices. Am J Clin Nutr 1981; 34: 2521–2529.Google Scholar
Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109: 45–60.Google Scholar
Frohlich ED, Grim C, Labarthe DR, Maxwell MH, Perloff D, Weidman WH. Recomendations for human blood pressure determination by sphygmomanometers: report of a special task force appointed by the steering committee. American Heart Association. Circulation 1988; 77: A501–A514.Google Scholar
Report of the second Task Force on blood pressure control in children. Pediatrics 1987; 79: 1–25.
Dissing J, Dahl O, Svensmark O. Phosphonic and arsonic acids as inhibitors of human red cell acid phosphatase and their use in affinity chromatography. Biochim Biophys Acta 1979; 569: 159–176.Google Scholar
Board PG, Pidcock ME. Methahemoglobinaemia resulting from heterozygosity for two NADH-Methaemoglobin redutase variants: characterization as NADH-Ferricyanide redutase. Br J Haematology 1981; 47: 361–370.Google Scholar
Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease. Circulation 1998; 97: 135–137.Google Scholar
Jacobs EG, Leung MP, Karlberg JP Postnatal growth in southern Chinese children with symptomatic congenital heart disease. J Pediatr Endocrinol Metab 2000; 13: 387–401.Google Scholar
Schuurmans FM, Pulles-Heintzberger CF, Gerver WJ, Kester AD, Forget PP. Long-term growth of children with congenital heart disease: a retrospective study. Acta Paediatr 1998; 87: 1250–1255.Google Scholar
Varan B, Tokel K, Yilmaz G. Malnutrition and growth failure in cyanotic and acyanotic congenital heart disease with and without pulmonary hypertension. Arch Dis Child 1999; 81: 49–52.Google Scholar
Chiarugi P and Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biocheml Sci 2003; 28: 509–514.Google Scholar
Cai H, Duarte N, Wilcken DE, Wang XL. NADH/NADPH oxidase p22 phox C242T polymorphism and coronary artery disease in the Australian population. Eur J Clin Invest 1999; 29: 744–748.Google Scholar
Wolf G, Panzer U, Harendza S, Wenzel U, Stahl RAK. No association between a genetic variant of the p22phox component of NAD(P)H oxidase and the incidence and progression of IgA nephropathy. Dial Transplant 2002; 17: 1509–1512.Google Scholar
Mata-Balaguer T, de la Herran R, Ruiz-Rejon C, Ruiz-Rejon M, Garrido-Ramos MA, Ruiz-Rejon F. Angiotensin-converting enzyme and p22(phox) polymorphisms and the risk of coronary heart disease in a low-risk Spanish population. Int J Cardiol 2004; 95: 145–151.Google Scholar
Hecht D, Zick Y. Selective inhibition of protein tyrosine phosphatase activities by H2O2 and vanadate in vitro. Bioch and Biophys Res Communications 1992; 188: 773–779.Google Scholar
Goyal P, Weissmann N, Grimminger F, et al. Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radic Biol Med 2004; 36: 1279–1288.Google Scholar
Krick S, Hanze J, Eul B, et al. Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1alpha and an autocrine angiotensin system. FASEB J 2005; 19: 857–883.Google Scholar
Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 2004; 104: 2073–2080.Google Scholar
Huang Z, Shiva S, Kim-Shapiro DB, et al. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 2005; 115: 2099–2107.Google Scholar